市场调查报告书
商品编码
1503390
到 2030 年内视镜设备市场预测 - 按产品类型、治疗和程序、技术、最终用户和地理位置进行的全球分析Endoscopy Devices Market Forecasts to 2030 - Global Analysis By Product Type, Treatment & Procedure, Technology, End User and By Geography |
根据 Stratistics MRC 的数据,2024 年全球内视镜设备市场规模为 319 亿美元,预计到 2030 年将达到 468 亿美元,预测期内复合年增长率为 6.6%。内视镜设备是用于在人体内部器官和腔内进行可视化、诊断和治疗干预的专用医疗仪器。这些设备通常由一根末端带有灯和摄影机的柔性管组成,可实现微创手术。它们通常用于胃肠病学、肺病学和妇科,以检查胃肠道、呼吸系统和生殖器官等区域。
根据世界卫生组织 (WHO) 统计,全球市场上估计有 200 万种不同类型的医疗器械,分为 7,000 多个通用器械组。
慢性病盛行率增加
胃肠道疾病、癌症和心血管疾病等慢性疾病的盛行率不断上升,是内视镜设备市场的重要驱动力。这些情况通常需要诊断和治疗内视镜手术,导致对内视镜设备的需求增加。内视镜手术能够提供微创解决方案,恢復时间更快,併发症更少,进一步提高了其采用率,推动市场成长。
内视镜设备成本高
内视镜设备的高成本是市场的主要限制因素。先进的内视镜设备和系统,例如高清视觉化系统和机器人辅助内视镜,价格昂贵。这可能会限制它们的采用,特别是在预算有限的发展中地区。高昂的初始投资和维护成本也可能成为小型医疗机构的障碍,影响整体市场成长。
转向个人化医疗
向个人化医疗的转变为内视镜设备市场提供了重大机会。个人化医疗涉及根据每个患者的个别特征制定医疗治疗方案,这需要精确的诊断工具。内视镜设备能够提供详细的内部视野和有针对性的活检,非常适合个人化的诊断和治疗程序。这一趋势预计将推动先进内视镜技术的创新和采用。
缺乏熟练的专业人员
缺乏熟练的专业人员是内视镜设备市场的一个显着威胁。内视镜手术需要训练有素且经验丰富的医疗保健专业人员,以确保准确的诊断和有效的治疗。缺乏训练有素的内视镜医师和技术人员可能会限制先进内视镜设备的最佳利用,导致性能不佳和潜在的併发症。这种短缺也阻碍了新技术的采用,限制了市场的成长。
Covid-19 大流行对内视镜设备市场产生了重大影响。在大流行的早期阶段,包括许多内视镜检查在内的选择性手术被推迟或取消,以优先为 Covid-19 患者提供资源并降低病毒传播的风险。这导致内视镜设备的需求暂时下降。然而,随着医疗保健系统适应并实施安全措施,在恢復延迟的手术以及人们对早期诊断重要性的认识提高的推动下,市场开始復苏。
预计内视镜领域在预测期内将是最大的
预计内视镜细分市场在预测期内将是最大的。内视镜是内视镜手术中使用的主要工具,可直接观察内部器官和组织。慢性病的盛行率不断上升以及对微创手术的日益偏好推动了对内视镜的需求。高清成像和柔性内视镜等技术进步进一步提高了其实用性和采用率,为市场成长做出了重大贡献。
预计门诊手术中心 (ASC) 领域在预测期内的复合年增长率最高
预计门诊手术中心 (ASC) 领域在预测期内的复合年增长率最高。 ASC 为医院手术提供了经济高效的替代方案,提供门诊手术服务。人们越来越倾向于在 ASC 中进行微创手术,这推动了这些环境中对内视镜设备的需求。 ASC 的便利性、住院时间的缩短和成本的降低使其成为患者和医疗保健提供者的有吸引力的选择,从而推动了市场的成长。
北美地区在内视镜设备市场占有主导地位。先进的医疗基础设施、医疗技术的广泛采用以及胃肠道和慢性疾病发病率的上升等因素促成了该地区的市场领导地位。主要市场参与者的存在和内视镜手术的优惠报销政策进一步支持了北美市场的成长。
亚太地区预计内视镜设备市场将快速成长。该地区的成长得益于医疗保健投资的增加、医疗基础设施的改善以及早期诊断和治疗意识的提高。慢性病的高盛行率,加上老年人口的不断增长,增加了对内视镜手术的需求。此外,先进内视镜技术的采用以及中国和印度等新兴经济体医疗保健服务的扩展也促进了该地区的高成长率。
2024 年 4 月,致力于将外科医生与患者之间的界面数位化的医疗器械公司 Asensus Surgical, Inc. 宣布与 KARL STORZ SE 签订了一份不具约束力的意向书(以下简称“意向书”) & Co. KG,一家独立的家族式全球医疗技术公司(“KARL STORZ”)就KARL STORZ 可能收购Asensus 的潜在交易条款进行尽职调查和谈判。在签署意向书之前,Asensus 对各种策略选项进行了广泛的考虑,包括潜在的合作和授权交易、依赖筹集大量额外股本的单干策略、出售公司和其他潜在业务开发交易。
2024年3月,新维维医疗科技有限公司(简称「新维维医疗」)与全球领先的医疗科技公司波士顿科学公司再次携手,签署扩大策略合作安排。
2023年10月,致力于让人们的生活更健康、更安全、更充实的全球医疗科技公司奥林巴斯公司今天宣布向市场推出其下一代EVIS X1(TM)内视镜系统,该系统将于10月进行展示和演示。
According to Stratistics MRC, the Global Endoscopy Devices Market is accounted for $31.9 billion in 2024 and is expected to reach $46.8 billion by 2030 growing at a CAGR of 6.6% during the forecast period. Endoscopy devices are specialized medical instruments used to visualize, diagnose, and perform therapeutic interventions within the body's internal organs and cavities. These devices typically consist of a flexible tube with a light and a camera at the end, allowing for minimally invasive procedures. They are commonly employed in gastroenterology, pulmonology, and gynecology to inspect areas such as the gastrointestinal tract, respiratory system, and reproductive organs.
According to the World Health Organization (WHO), there are an estimated 2 million different kinds of medical devices on the world market, categorized into more than 7,000 generic device groups.
Increasing prevalence of chronic diseases
The rising prevalence of chronic diseases such as gastrointestinal disorders, cancer, and cardiovascular diseases is a significant driver for the endoscopy devices market. These conditions often require diagnostic and therapeutic endoscopic procedures, leading to increased demand for endoscopy devices. The ability of endoscopic procedures to provide minimally invasive solutions with quicker recovery times and fewer complications further boosts their adoption, driving market growth.
High cost of endoscopic equipment
The high cost of endoscopic equipment is a major restraint for the market. Advanced endoscopic devices and systems, such as high-definition visualization systems and robotic-assisted endoscopes, come with substantial price tags. This can limit their adoption, especially in developing regions with budget constraints. The high initial investment and maintenance costs can also be a barrier for smaller healthcare facilities, impacting overall market growth.
Shift towards personalized medicine
The shift towards personalized medicine presents a significant opportunity for the endoscopy devices market. Personalized medicine involves tailoring medical treatment to the individual characteristics of each patient, which requires precise diagnostic tools. Endoscopy devices, with their ability to provide detailed internal views and targeted biopsies, are well-suited for personalized diagnostic and therapeutic procedures. This trend is expected to drive innovation and adoption of advanced endoscopic technologies.
Lack of skilled professionals
The lack of skilled professionals is a notable threat to the endoscopy devices market. Endoscopic procedures require highly trained and experienced healthcare professionals to ensure accurate diagnosis and effective treatment. The shortage of trained endoscopists and technicians can limit the optimal utilization of advanced endoscopy equipment, leading to underperformance and potential complications. This shortage also hampers the adoption of new technologies, restraining market growth.
The Covid-19 pandemic had a significant impact on the endoscopy devices market. During the early stages of the pandemic, elective procedures, including many endoscopic examinations, were postponed or canceled to prioritize resources for Covid-19 patients and reduce the risk of viral transmission. This led to a temporary decline in demand for endoscopy devices. However, as healthcare systems adapted and implemented safety measures, the market began to recover, driven by the resumption of postponed procedures and increased awareness of the importance of early diagnosis.
The endoscopes segment is expected to be the largest during the forecast period
The endoscopes segment is expected to be the largest during the forecast period. Endoscopes are the primary tools used in endoscopic procedures, providing direct visualization of internal organs and tissues. The increasing prevalence of chronic diseases and the growing preference for minimally invasive procedures drive the demand for endoscopes. Technological advancements, such as high-definition imaging and flexible endoscopes, further enhance their utility and adoption, contributing significantly to market growth.
The ambulatory surgery centers (ASCs) segment is expected to have the highest CAGR during the forecast period
The ambulatory surgery centers (ASCs) segment is expected to have the highest CAGR during the forecast period. ASCs offer cost-effective and efficient alternatives to hospital-based surgeries, providing outpatient surgical services. The increasing preference for minimally invasive procedures, which can be performed in ASCs, drives the demand for endoscopy devices in these settings. The convenience, reduced hospital stay, and lower costs associated with ASCs make them an attractive option for patients and healthcare providers, fueling market growth.
The North America region is positioned to dominate the Endoscopy Devices Market. Factors such as advanced healthcare infrastructure, high adoption of medical technologies, and a growing incidence of gastrointestinal and chronic diseases contribute to the region's market leadership. The presence of key market players and favorable reimbursement policies for endoscopic procedures further supports market growth in North America.
The Asia Pacific region anticipates rapid growth in the Endoscopy Devices Market. The region's growth is driven by increasing healthcare investments, improving medical infrastructure, and rising awareness of early diagnosis and treatment. The high prevalence of chronic diseases, coupled with a growing geriatric population, boosts the demand for endoscopic procedures. Additionally, the adoption of advanced endoscopic technologies and the expansion of healthcare services in emerging economies like China and India contribute to the region's high growth rate.
Key players in the market
Some of the key players in Endoscopy Devices Market include Olympus Corporation, KARL STORZ SE & Co. KG, Boston Scientific Corporation, Johnson & Johnson (Ethicon), Stryker Corporation, Medtronic plc, Fujifilm Holdings Corporation, HOYA Corporation, Nipro Corporation, Smith & Nephew plc, Intuitive Surgical, Inc., Richard Wolf GmbH, Cook Medical, B. Braun Melsungen AG, ConMed Corporation, Ambu A/S, CapsoVision, Inc., Fortimedix Surgical B.V., The Cooper Companies, Inc. and Laborie Medical Technologies Inc.
In April 2024, Asensus Surgical, Inc. a medical device company that is digitizing the interface between the surgeon and the patient, announced that it has entered into a non-binding letter of intent (the "letter of intent") with KARL STORZ SE & Co. KG, an independent, family-owned global medical technology company ("KARL STORZ") to engage in diligence and negotiations regarding the terms of a potential transaction whereby KARL STORZ may acquire Asensus. Entry into the letter of intent follows an extensive period of consideration of various strategic alternatives by Asensus, including potential collaboration and licensing transactions, a go-it-alone strategy dependent upon raising significant additional equity capital, a sale of the Company and other potential business development transactions.
In March 2024, Scivita Medical Technology Co., Ltd. ("Scivita Medical") and Boston Scientific Corporation, a leading global medical technology company, joined hands again to sign an expanded strategic cooperation arrangement.
In October 2023, Olympus Corporation, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, announced today the market launch of its next-generation EVIS X1(TM) endoscopy system, which will be on display and demonstrated Oct. 22-24 during the American College of Gastroenterology (ACG) annual meeting in Vancouver, Canada.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.